SWM
ARRY

SeaCrest Wealth Management’s Array Biopharma Inc ARRY Stock Holding History

SeaCrest Wealth Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-500
Closed -$12K – 2155
2019
Q1 		$12K Buy
500
+200
+67% +$4.16K ﹤0.01% 1484
2018
Q4 		$4K Hold
300
– – ﹤0.01% 1794
2018
Q3 		$5K Hold
300
– – ﹤0.01% 1891
2018
Q2 		$5K Hold
300
– – ﹤0.01% 1845
2018
Q1 		$5K Hold
300
– – ﹤0.01% 1817
2017
Q4 		$4K Buy
+300
New +$3.41K ﹤0.01% 1893

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SeaCrest Wealth Management's ARRY Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 500 shares — an estimated $12K sold.

SeaCrest Wealth Management first reported a position in ARRY in Q4 2017 and held it in 6 quarters. The position peaked at $12K in Q1 2019. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • SeaCrest Wealth Management reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 500 Array Biopharma Inc shares in Q2 2019, an estimated $12K.
  • SeaCrest Wealth Management first reported a position in Array Biopharma Inc in Q4 2017 and held it in 6 quarters.
  • SeaCrest Wealth Management's Array Biopharma Inc position peaked at $12K in Q1 2019.
  • 318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.